157 related articles for article (PubMed ID: 8515098)
1. Randomized, placebo-controlled trial of rifampin, ethambutol, and ciprofloxacin for AIDS patients with disseminated Mycobacterium avium complex infection.
Jacobson MA; Yajko D; Northfelt D; Charlebois E; Gary D; Brosgart C; Sanders CA; Hadley WK
J Infect Dis; 1993 Jul; 168(1):112-9. PubMed ID: 8515098
[TBL] [Abstract][Full Text] [Related]
2. Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group.
Chiu J; Nussbaum J; Bozzette S; Tilles JG; Young LS; Leedom J; Heseltine PN; McCutchan JA
Ann Intern Med; 1990 Sep; 113(5):358-61. PubMed ID: 2382918
[TBL] [Abstract][Full Text] [Related]
3. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM
N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931
[TBL] [Abstract][Full Text] [Related]
4. A phase II/III trial of antimicrobial therapy with or without amikacin in the treatment of disseminated Mycobacterium avium infection in HIV-infected individuals. AIDS Clinical Trials Group Protocol 135 Study Team.
Parenti DM; Williams PL; Hafner R; Jacobs MR; Hojczyk P; Hooton TM; Barber TW; Simpson G; van der Horst C; Currier J; Powderly WG; Limjoco M; Ellner JJ
AIDS; 1998 Dec; 12(18):2439-46. PubMed ID: 9875582
[TBL] [Abstract][Full Text] [Related]
5. The individual microbiologic effect of three antimycobacterial agents, clofazimine, ethambutol, and rifampin, on Mycobacterium avium complex bacteremia in patients with AIDS.
Kemper CA; Havlir D; Haghighat D; Dubé M; Bartok AE; Sison JP; Yao Y; Yangco B; Leedom JM; Tilles JG
J Infect Dis; 1994 Jul; 170(1):157-64. PubMed ID: 8014492
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. The California Collaborative Treatment Group.
Kemper CA; Meng TC; Nussbaum J; Chiu J; Feigal DF; Bartok AE; Leedom JM; Tilles JG; Deresinski SC; McCutchan JA
Ann Intern Med; 1992 Mar; 116(6):466-72. PubMed ID: 1739237
[TBL] [Abstract][Full Text] [Related]
7. Low serum levels of oral antimycobacterial agents in patients with disseminated Mycobacterium avium complex disease.
Gordon SM; Horsburgh CR; Peloquin CA; Havlik JA; Metchock B; Heifets L; McGowan JE; Thompson SE
J Infect Dis; 1993 Dec; 168(6):1559-62. PubMed ID: 8245546
[TBL] [Abstract][Full Text] [Related]
8. A cutaneous lesion in a patient with AIDS: an unusual presentation of infection due to Mycobacterium avium complex.
Clark JA; Margolis DM
Clin Infect Dis; 1993 Apr; 16(4):555-7. PubMed ID: 8513064
[TBL] [Abstract][Full Text] [Related]
9. Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial.
Dautzenberg B; Truffot C; Legris S; Meyohas MC; Berlie HC; Mercat A; Chevret S; Grosset J
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):564-9. PubMed ID: 1832527
[TBL] [Abstract][Full Text] [Related]
10. Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study Group.
Singer J; Thorne A; Khorasheh S; Raboud JM; Wu AW; Salit I; Tsoukas CM; Lemieux C; Shafran SD
Int J STD AIDS; 2000 Apr; 11(4):212-9. PubMed ID: 10772083
[TBL] [Abstract][Full Text] [Related]
11. Randomized, open-label trial of azithromycin plus ethambutol vs. clarithromycin plus ethambutol as therapy for Mycobacterium avium complex bacteremia in patients with human immunodeficiency virus infection. Veterans Affairs HIV Research Consortium.
Ward TT; Rimland D; Kauffman C; Huycke M; Evans TG; Heifets L
Clin Infect Dis; 1998 Nov; 27(5):1278-85. PubMed ID: 9827282
[TBL] [Abstract][Full Text] [Related]
12. Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection.
Chaisson RE; Keiser P; Pierce M; Fessel WJ; Ruskin J; Lahart C; Benson CA; Meek K; Siepman N; Craft JC
AIDS; 1997 Mar; 11(3):311-7. PubMed ID: 9147422
[TBL] [Abstract][Full Text] [Related]
13. A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex.
Gordin FM; Sullam PM; Shafran SD; Cohn DL; Wynne B; Paxton L; Perry K; Horsburgh CR
Clin Infect Dis; 1999 May; 28(5):1080-5. PubMed ID: 10452638
[TBL] [Abstract][Full Text] [Related]
14. Long-term Follow-up of Mycobacterium avium Complex Lung Disease in Patients Treated With Regimens Including Clofazimine and/or Rifampin.
Jarand J; Davis JP; Cowie RL; Field SK; Fisher DA
Chest; 2016 May; 149(5):1285-93. PubMed ID: 26513209
[TBL] [Abstract][Full Text] [Related]
15. Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group.
Dubé MP; Torriani FJ; See D; Havlir DV; Kemper CA; Leedom JM; Tilles JG; McCutchan JA; Sattler FR
Clin Infect Dis; 1999 Jan; 28(1):136-8. PubMed ID: 10028084
[TBL] [Abstract][Full Text] [Related]
16. Treatment of disseminated disease due to the Mycobacterium avium complex in patients with AIDS.
Benson CA
Clin Infect Dis; 1994 Apr; 18 Suppl 3():S237-42. PubMed ID: 8204776
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Myocardium avium complex infection: does the beige mouse model predict therapeutic outcome in humans?
Sison JP; Yao Y; Kemper CA; Hamilton JR; Brummer E; Stevens DA; Deresinski SC
J Infect Dis; 1996 Mar; 173(3):750-3. PubMed ID: 8627046
[TBL] [Abstract][Full Text] [Related]
18. A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome.
Benson CA; Williams PL; Currier JS; Holland F; Mahon LF; MacGregor RR; Inderlied CB; Flexner C; Neidig J; Chaisson R; Notario GF; Hafner R;
Clin Infect Dis; 2003 Nov; 37(9):1234-43. PubMed ID: 14557969
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind trial comparing azithromycin and clarithromycin in the treatment of disseminated Mycobacterium avium infection in patients with human immunodeficiency virus.
Dunne M; Fessel J; Kumar P; Dickenson G; Keiser P; Boulos M; Mogyros M; White AC; Cahn P; O'Connor M; Lewi D; Green S; Tilles J; Hicks C; Bissett J; Schneider MM; Benner R
Clin Infect Dis; 2000 Nov; 31(5):1245-52. PubMed ID: 11073759
[TBL] [Abstract][Full Text] [Related]
20. Mycobacterium avium complex infection. Pharmacokinetic and pharmacodynamic considerations that may improve clinical outcomes.
Peloquin CA
Clin Pharmacokinet; 1997 Feb; 32(2):132-44. PubMed ID: 9068928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
